1
|
Staples KJ, Williams NP, Bonduelle O, Hutton AJ, Cellura D, Marriott AC, Combadière B, Wilkinson TMA. Acquired immune responses to the seasonal trivalent influenza vaccination in COPD. Clin Exp Immunol 2019; 198:71-82. [PMID: 31161649 PMCID: PMC6718283 DOI: 10.1111/cei.13336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/29/2019] [Indexed: 11/28/2022] Open
Abstract
Epidemiological data suggest that influenza vaccination protects against all‐cause mortality in chronic obstructive pulmonary disease (COPD) patients. However, recent work has suggested there is a defect in the ability of some COPD patients to mount an adequate humoral response to influenza vaccination. The aim of our study was to investigate humoral and cell‐mediated vaccine responses to the seasonal trivalent influenza vaccination (TIV) in COPD subjects and healthy controls. Forty‐seven subjects were enrolled into the study; 23 COPD patients, 13 age‐matched healthy controls (HC ≥ 50) and 11 young healthy control subjects (YC ≤ 40). Serum and peripheral blood mononuclear cells (PBMC) were isolated pre‐TIV vaccination and at days 7 and 28 and 6 months post‐vaccine for haemagglutinin inhibition (HAI) titre, antigen‐specific T cell and antibody‐secreting cell analysis. The kinetics of the vaccine response were similar between YC, HC and COPD patients and there was no significant difference in antibody titres between these groups at 28 days post‐vaccine. As we observed no disease‐dependent differences in either humoral or cellular responses, we investigated if there was any association of these measures with age. H1N1 (r = −0·4253, P = 0·0036) and influenza B (r = −0·344, P = 0·0192) antibody titre at 28 days negatively correlated with age, as did H1N1‐specific CD4+ T helper cells (r = −0·4276, P = 0·0034). These results suggest that age is the primary determinant of response to trivalent vaccine and that COPD is not a driver of deficient responses per se. These data support the continued use of the yearly trivalent vaccine as an adjunct to COPD disease management.
Collapse
Affiliation(s)
- K J Staples
- Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital, Tremona Road, Southampton, UK.,Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Tremona Road, Southampton, UK
| | - N P Williams
- Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital, Tremona Road, Southampton, UK.,Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Tremona Road, Southampton, UK
| | - O Bonduelle
- Sorbonne Universités, UPMC Univ Paris 06, Unité Mixte de Recherche de Santé (UMR S) CR7, Centre d'Immunologie et des Maladies Infectieuses -Paris (Cimi-Paris), Paris, France.,Institut National de Santé et de Recherche Médicale (INSERM) U1135, Cimi-Paris, Paris, France
| | - A J Hutton
- Sorbonne Universités, UPMC Univ Paris 06, Unité Mixte de Recherche de Santé (UMR S) CR7, Centre d'Immunologie et des Maladies Infectieuses -Paris (Cimi-Paris), Paris, France
| | - D Cellura
- Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital, Tremona Road, Southampton, UK
| | - A C Marriott
- National Infection Service, Public Health England, Porton Down, UK
| | - B Combadière
- Sorbonne Universités, UPMC Univ Paris 06, Unité Mixte de Recherche de Santé (UMR S) CR7, Centre d'Immunologie et des Maladies Infectieuses -Paris (Cimi-Paris), Paris, France.,Institut National de Santé et de Recherche Médicale (INSERM) U1135, Cimi-Paris, Paris, France
| | - T M A Wilkinson
- Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital, Tremona Road, Southampton, UK.,Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Tremona Road, Southampton, UK.,Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Tremona Road, Southampton, UK
| |
Collapse
|
2
|
Gonnet J, Perrin H, Hutton AJ, Boccara D, Bonduelle O, Mimoun M, Atlan M, Soria A, Combadière B. Interleukin-32 promotes detachment and activation of human Langerhans cells in a human skin explant model. Br J Dermatol 2018; 179:145-153. [PMID: 29806155 DOI: 10.1111/bjd.16721] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/04/2018] [Indexed: 12/15/2022]
Abstract
BACKGROUND Cross-talk between skin keratinocytes (KCs) and Langerhans cells (LCs) plays a fundamental role in the body's first line of immunological defences. However, the mechanism behind the interaction between these two major epidermal cells is unknown. Interleukin (IL)-32 is produced in inflammatory skin disorders. We questioned the role of IL-32 in the epidermis. OBJECTIVES We aimed to determine the role of IL-32 produced by KCs on surrounding LCs. METHODS We used an ex vivo human explant model from healthy donors and investigated the role of IL-32 on LC activation using imaging, flow cytometry, reverse transcriptase quantitative polymerase chain reaction and small interfering (si)RNA treatment. RESULTS Modified vaccinia virus ankara (MVA) infection induced KC death alongside the early production of the proinflammatory cytokine IL-32. We demonstrated that IL-32 produced by MVA-infected KCs induced modest but significant morphological changes in LCs and downregulation of adhesion molecules, such as epithelial cell adhesion molecule and very late antigen-4, and CXCL10 production. The treatment of KCs with IL-32-specific siRNA, and anti-IL-32 blocking antibody significantly inhibited LC activation, demonstrating the role of IL-32 in LC activation. We also found that some Toll-like receptor ligands induced a very high level of IL-32 production by KCs, which initiated LC activation. CONCLUSIONS We propose, for the first time, that IL-32 is a molecular link between KCs and LCs in healthy skin, provoking LC migration from the epidermis to the dermis prior to their migration to the draining lymph nodes.
Collapse
Affiliation(s)
- J Gonnet
- Sorbonne Universités UPMC Université Paris 06, UMRS CR7, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses-Paris (Cimi-Paris), 91 Boulevard de l'Hôpital, 75013, Paris, France
| | - H Perrin
- Sorbonne Universités UPMC Université Paris 06, UMRS CR7, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses-Paris (Cimi-Paris), 91 Boulevard de l'Hôpital, 75013, Paris, France
| | - A J Hutton
- Sorbonne Universités UPMC Université Paris 06, UMRS CR7, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses-Paris (Cimi-Paris), 91 Boulevard de l'Hôpital, 75013, Paris, France
| | - D Boccara
- Sorbonne Universités UPMC Université Paris 06, UMRS CR7, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses-Paris (Cimi-Paris), 91 Boulevard de l'Hôpital, 75013, Paris, France.,Service de Chirurgie Plastique Reconstructrice, Esthétique, Centre des Brûlés, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), 1 avenue Claude Vellefaux, 75010, Paris, France
| | - O Bonduelle
- Sorbonne Universités UPMC Université Paris 06, UMRS CR7, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses-Paris (Cimi-Paris), 91 Boulevard de l'Hôpital, 75013, Paris, France
| | - M Mimoun
- Service de Chirurgie Plastique Reconstructrice, Esthétique, Centre des Brûlés, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), 1 avenue Claude Vellefaux, 75010, Paris, France
| | - M Atlan
- Service de Chirurgie Plastique Reconstructrice et Esthétique, Hôpital Tenon, Assistance Publique Hôpitaux de Paris (APHP), 4 Rue de la Chine, 75020, Paris, France
| | - A Soria
- Sorbonne Universités UPMC Université Paris 06, UMRS CR7, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses-Paris (Cimi-Paris), 91 Boulevard de l'Hôpital, 75013, Paris, France.,Service de Dermatologie et d'Allergologie, Hôpital Tenon, Hôpitaux Universitaire Est Parisien (HUEP), Assistance Publique Hôpitaux de Paris (APHP), 4 rue de la Chine, 75020, Paris, France
| | - B Combadière
- Sorbonne Universités UPMC Université Paris 06, UMRS CR7, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses-Paris (Cimi-Paris), 91 Boulevard de l'Hôpital, 75013, Paris, France
| |
Collapse
|
3
|
Galban-Horcajo F, Fitzpatrick AM, Hutton AJ, Dunn SM, Kalna G, Brennan KM, Rinaldi S, Yu RK, Goodyear CS, Willison HJ. Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy. Eur J Neurol 2012; 20:62-70. [PMID: 22727042 DOI: 10.1111/j.1468-1331.2012.03767.x] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2012] [Accepted: 04/24/2012] [Indexed: 11/29/2022]
Abstract
BACKGROUND Measurement of anti-GM1 IgM antibodies in multifocal motor neuropathy (MMN) sera is confounded by relatively low sensitivity that limits clinical usefulness. Combinatorial assay methods, in which antibodies react to heteromeric complexes of two or more glycolipids, are being increasingly applied to this area of diagnostic testing. METHODS A newly developed combinatorial glycoarray able to identify antibodies to 45 different heteromeric glycolipid complexes and their 10 individual glycolipid components was applied to a randomly selected population of 33 MMN cases and 57 normal or disease controls. Comparison with an enzyme-linked immunosorbent assay (ELISA) was conducted for selected single glycolipids and their complexes. RESULTS By ELISA, 22/33 MMN cases had detectable anti-GM1 IgM antibodies, whereas 19/33 MMN samples were positive for anti-GM1 antibodies by glycoarray. Analysis of variance (anova) revealed that of the 55 possible single glycolipids and their 1:1 complexes, antibodies to the GM1:galactocerebroside (GM1:GalC) complex were most significantly associated with MMN, returning 33/33 MMN samples as positive by glycoarray and 29/33 positive by ELISA. Regression analysis revealed a high correlation in absolute values between ELISA and glycoarray. Receiver operator characteristic analysis revealed insignificantly different diagnostic performance between the two methods. However, the glycoarray appeared to offer slightly improved sensitivity by identifying antibodies in four ELISA-negative samples. CONCLUSIONS The use of combinatorial glycoarray or ELISA increased the diagnostic sensitivity of anti-glycolipid antibody testing in this cohort of MMN cases, without significantly affecting specificity, and may be a useful assay modification for routine clinical screening.
Collapse
Affiliation(s)
- F Galban-Horcajo
- Glasgow Biomedical Research Centre, College of Medical, Veterinary and Life Science, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|